207 related articles for article (PubMed ID: 27481400)
1. Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host.
Mullane KM; Nuss C; Ridgeway J; Prichard MN; Hartline CB; Theusch J; Mommeja-Marin H; Larson RA
Transpl Infect Dis; 2016 Oct; 18(5):785-790. PubMed ID: 27481400
[TBL] [Abstract][Full Text] [Related]
2. Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation.
Voigt S; Hofmann J; Edelmann A; Sauerbrei A; Kühl JS
Transpl Infect Dis; 2016 Oct; 18(5):791-794. PubMed ID: 27482652
[TBL] [Abstract][Full Text] [Related]
3. Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
Venard V; Dauendorffer JN; Carret AS; Corsaro D; Edert D; Bordigoni P; Le Faou A
Pathol Biol (Paris); 2001 Sep; 49(7):553-8. PubMed ID: 11642018
[TBL] [Abstract][Full Text] [Related]
4. [Infection due to acyclovir-resistant varicella-zoster herpes virus in a patient with AIDS].
Ramos C; Lajusticia J
Enferm Infecc Microbiol Clin; 2004 Apr; 22(4):253-4. PubMed ID: 15056447
[No Abstract] [Full Text] [Related]
5. Efficacy of brincidofovir as prophylaxis against HSV and VZV in hematopoietic cell transplant recipients.
Lee YJ; Neofytos D; Kim SJ; Cheteyan L; Huang YT; Papadopoulos EB; Jakubowski AA; Papanicolaou GA
Transpl Infect Dis; 2018 Dec; 20(6):e12977. PubMed ID: 30120866
[TBL] [Abstract][Full Text] [Related]
6. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
Tan HH; Goh CL
Am J Clin Dermatol; 2006; 7(1):13-29. PubMed ID: 16489840
[TBL] [Abstract][Full Text] [Related]
7. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience.
El-Haddad D; El Chaer F; Vanichanan J; Shah DP; Ariza-Heredia EJ; Mulanovich VE; Gulbis AM; Shpall EJ; Chemaly RF
Antiviral Res; 2016 Oct; 134():58-62. PubMed ID: 27582067
[TBL] [Abstract][Full Text] [Related]
8. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
Reusser P
J Hosp Infect; 1996 Aug; 33(4):235-48. PubMed ID: 8864937
[TBL] [Abstract][Full Text] [Related]
9. The Successful Treatment of a Cord Blood Transplant Recipient with Varicella Zoster Virus Meningitis, Radiculitis and Myelitis with Foscarnet.
Shimizu R; Ohwada C; Nagao Y; Togasaki E; Kawajiri C; Muto T; Tsukamoto S; Sakai S; Takeda Y; Mimura N; Takeuchi M; Sakaida E; Iseki T; Nakaseko C
Intern Med; 2017; 56(3):353-356. PubMed ID: 28154282
[TBL] [Abstract][Full Text] [Related]
10. Successful clearance of cutaneous acyclovir-resistant, foscarnet-refractory herpes virus lesions with topical cidofovir in an allogeneic hematopoietic stem cell transplant patient.
Muluneh B; Dean A; Armistead P; Khan T
J Oncol Pharm Pract; 2013 Jun; 19(2):181-5. PubMed ID: 22635417
[TBL] [Abstract][Full Text] [Related]
11. Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older.
Arora A; Mendoza N; Brantley J; Yates B; Dix L; Tyring S
J Infect Dis; 2008 May; 197(9):1289-95. PubMed ID: 18422441
[TBL] [Abstract][Full Text] [Related]
12. Antiviral agents for non-human immunodeficiency virus infections.
Keating MR
Mayo Clin Proc; 1999 Dec; 74(12):1266-83. PubMed ID: 10593357
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
Seang S; Boutolleau D; Burrel S; Regnier S; Epelboin L; Voujon D; Valantin MA; Katlama C; Agut H; Caumes E
Int J STD AIDS; 2014 Aug; 25(9):676-82. PubMed ID: 24535691
[TBL] [Abstract][Full Text] [Related]
14. Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
Arnulf B; Chebbi F; Lefrere F; Ait Arkoub Z; Varet B; Fillet AM
Bone Marrow Transplant; 2001 Oct; 28(8):799-801. PubMed ID: 11781635
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and risk factors for developing varicella zoster virus dissemination following hematopoietic stem cell transplantation.
Umezawa Y; Kakihana K; Oshikawa G; Kobayashi T; Doki N; Sakamaki H; Ohashi K
Transpl Infect Dis; 2014 Apr; 16(2):195-202. PubMed ID: 24438510
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child.
Bryant P; Sasadeusz J; Carapetis J; Waters K; Curtis N
Pediatr Infect Dis J; 2001 Nov; 20(11):1083-6. PubMed ID: 11734717
[TBL] [Abstract][Full Text] [Related]
18. Prevention of VZV infection in immunosuppressed patients using antiviral agents.
Boeckh M
Herpes; 2006 Nov; 13(3):60-5. PubMed ID: 17147908
[TBL] [Abstract][Full Text] [Related]
19. A rare case of disseminated shingles in an immunocompetent patient following a 7-day treatment with oral valacyclovir.
Burdett C; Mendoza N; Arora A; Bartlett B; Gewirtzman A; Tremaine AM; Tyring S
J Clin Virol; 2008 Oct; 43(2):233-5. PubMed ID: 18771948
[No Abstract] [Full Text] [Related]
20. Intravitreal foscarnet for the treatment of acyclovir-resistant acute retinal necrosis caused by varicella zoster virus.
Lee MY; Kim KS; Lee WK
Ocul Immunol Inflamm; 2011 Jun; 19(3):212-3. PubMed ID: 21595539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
